Publications

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

 78
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

Next Article

LSD analogue with potential for treating schizophrenia

Related Posts

Alpha-synuclein mutations mislocalize cytoplasmic p300 compromising autophagy, which is rescued by ACLY inhibition

Alpha-synuclein mutations mislocalize cytoplasmic p300 ...

 82

A sequence bottleneck for animal intelligence and language?

A sequence bottleneck for animal intelligence and langu...

 51

Selenoprotein P is a target for regulating extracellular vesicle biogenesis and secretion from activated microglia in vivo

Selenoprotein P is a target for regulating extracellula...

 65